摘要 |
<p>Disclosed is a compound represented by the formula (1) below or a pharmaceutically acceptable salt thereof. [chemical formula 1] (1) (In the formula, the configuration of a carbon atom marked with an asterisk (*) is R; R<SUP>1</SUP> represents a hydrogen atom, a halogen atom, an amino group, a hydroxy group, a hydroxyamino group, a nitro group, a cyano group, a sulfamoyl group, a C<SUB>1</SUB>-C<SUB>6</SUB> alkyl group or a C<SUB>1</SUB>-C<SUB>6</SUB> alkoxy group; R<SUP>2</SUP> represents a C<SUB>3</SUB>-C<SUB>6</SUB> cycloalkylsulfanyl group, a C<SUB>3</SUB>-C<SUB>6</SUB> cycloalkylsulfinyl group or a C<SUB>3</SUB>-C<SUB>6</SUB> cycloalkylsulfonyl group; and A represents an optionally substituted heteroaryl group.)</p> |
申请人 |
KYORIN PHARMACEUTICAL CO., LTD.;TEIJIN PHARMA LIMITED;FUKUDA, YASUMICHI;ASAHINA, YOSHIKAZU;TAKADOI, MASANORI;OHATA, KOHEI;IDE, TOMOHIRO;KOBAYASHI, FUMIYOSHI;KOBAYASHI, SHINJI;KOMATSU, KANJI;YAMAMOTO, MASANORI |
发明人 |
FUKUDA, YASUMICHI;ASAHINA, YOSHIKAZU;TAKADOI, MASANORI;OHATA, KOHEI;IDE, TOMOHIRO;KOBAYASHI, FUMIYOSHI;KOBAYASHI, SHINJI;KOMATSU, KANJI;YAMAMOTO, MASANORI |